NVAX logo

NVAX
Novavax Inc

107,649
Mkt Cap
$1.33B
Volume
2.79M
52W High
$11.97
52W Low
$5.01
PE Ratio
3.37
NVAX Fundamentals
Price
$8.02
Prev Close
$8.14
Open
$8.19
50D MA
$9.37
Beta
1.42
Avg. Volume
4.31M
EPS (Annual)
$2.54
P/B
-10.21
Rev/Employee
$1.5M
$695.34
Loading...
Loading...
News
all
press releases
Novavax (NVAX) Stock Dips While Market Gains: Key Facts
In the closing of the recent trading day, Novavax (NVAX) stood at $8.02, denoting a -1.47% move from the preceding trading day.
Zacks·4h ago
News Placeholder
More News
News Placeholder
Shah Capital Management Purchases 2,747,000 Shares of Novavax, Inc. $NVAX
Shah Capital Management increased its position in Novavax, Inc. (NASDAQ:NVAX - Free Report) by 23.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·2d ago
News Placeholder
Novavax (NASDAQ:NVAX) Stock Price Passes Above 200 Day Moving Average - Here's Why
Novavax (NASDAQ:NVAX) Share Price Passes Above 200-Day Moving Average - What's Next...
MarketBeat·2d ago
News Placeholder
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks·3d ago
News Placeholder
Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development
Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development PR...
PR Newswire·3d ago
News Placeholder
Novavax (NVAX) Falls More Steeply Than Broader Market: What Investors Need to Know
In the most recent trading session, Novavax (NVAX) closed at $8.95, indicating a -4.18% shift from the previous trading day.
Zacks·6d ago
News Placeholder
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Zacks·10d ago
News Placeholder
Q3 Earnings Estimate for Novavax Issued By Zacks Research
Novavax, Inc. (NASDAQ:NVAX - Free Report) - Analysts at Zacks Research issued their Q3 2027 earnings per share estimates for shares of Novavax in a research report issued on Thursday, March 19th. Zacks Research analyst Team expects that the biopharmaceutical company will earn ($0.01) per share for t...
MarketBeat·10d ago
News Placeholder
Novavax (NVAX) Stock Moves -1.23%: What You Should Know
Novavax (NVAX) closed at $9.62 in the latest trading session, marking a -1.23% move from the prior day.
Zacks·12d ago
News Placeholder
Novavax, Inc. (NASDAQ:NVAX) Given Average Rating of "Hold" by Brokerages
Shares of Novavax, Inc. (NASDAQ:NVAX - Get Free Report) have earned a consensus recommendation of "Hold" from the ten ratings firms that are currently covering the stock, Marketbeat Ratings reports...
MarketBeat·14d ago
<
1
2
...
>

Latest NVAX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.